Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
7,903,678
-
Share change
-
+405,038
-
Total reported value
-
$49,366,000
-
Put/Call ratio
-
508%
-
Price per share
-
$6.32
-
Number of holders
-
37
-
Value change
-
+$2,608,673
-
Number of buys
-
11
-
Number of sells
-
10
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK) as of Q1 2022
As of 31 Mar 2022,
MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,903,678 shares.
The largest 10 holders included
Newtyn Management, LLC, 22NW, LP, Western Standard LLC, VANGUARD GROUP INC, Bronte Capital Management Pty Ltd., Nantahala Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, Point72 Asset Management, L.P., Sepio Capital, LP, and BlackRock Inc..
This page lists
37
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.